Bệnh viện Đa khoa Quốc tế Thu Cúc

Name

Bệnh viện Đa khoa Quốc tế Thu Cúc

Legal name

Bệnh viện Đa khoa Quốc tế Thu Cúc

Website

https://ungbuouvietnam.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Cancer treatment services
• Oncology hospital
• Preventive cancer screening
• Multimodal oncology care
• Medical diagnostics

Headquarters

HQ city

Hanoi

HQ country

Vietnam

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Oncology Consultation and Treatment Services: The hospital generates revenue through outpatient consultations, inpatient cancer treatment, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and surgical procedures performed by its Singapore and Vietnamese oncology team.
2. Cancer Screening and Diagnostic Packages: Revenue from structured cancer screening packages for various cancer types (breast, cervical, colorectal, lung, gastric, thyroid, etc.) offered at different price tiers with promotional discounts.
3. Health Insurance and Non-Life Insurance Billing: The hospital accepts Vietnam's national health insurance (BHYT) and various non-life insurance (bảo hiểm phi nhân thọ) plans, serving as a reimbursement channel for patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Bệnh viện Đa khoa Quốc tế Thu Cúc operates a private Singapore Oncology Department (Khoa Ung bướu Singapore) delivering Singapore-standard cancer screening, diagnosis, and multimodal treatment—including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy—directly to Vietnamese patients at its Hanoi campus in partnership with senior Singapore oncologists.

Product overview

Bệnh viện Đa khoa Quốc tế Thu Cúc operates a Singapore Oncology Department (Khoa Ung bướu Singapore) that provides comprehensive cancer care through integrated services including cancer screening packages, diagnostic testing (endoscopy, genetic testing), and multimodality treatment (surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy). The hospital partners with Singapore cancer specialists who provide direct consultation and treatment oversight, delivering Singapore-standard protocols in Vietnam. Services cover various cancer types including lung, breast, cervical, ovarian, colorectal, gastric, liver, and thyroid cancers.

Differentiator

Problem solved

Functional benefit

Products and services

• Khoa Ung bướu Singapore (Singapore Oncology Department) A specialized oncology department providing comprehensive cancer treatment services in partnership with Singapore cancer specialists, delivering treatment protocols equivalent to Singapore standards at 100% to Vietnamese patients at the Hanoi campus.
• Cancer Screening Services (Dịch vụ Tầm soát ung thư) Structured cancer screening and early detection packages covering breast, cervical, lung, colorectal, gastric, ovarian, and thyroid cancers, offered to individuals and families seeking preventive care, with promotional pricing such as 20% off during awareness campaigns.
• Cancer Treatment Services (Điều trị ung thư)
• Singapore-Standard Multimodal Treatment Protocol (Phác đồ điều trị đa mô thức chuẩn Singapore)
• Cancer Gene Testing (Xét nghiệm gene ung thư)
• Endoscopic Diagnostics (Nội soi chẩn đoán)
• Palliative Care (Chăm sóc giảm nhẹ)

Quantifiable outcome

• Cancer cure rate exceeds 90% when detected at early stages
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• National University Hospital of Singapore (NUHS)coreStrategic or Co-development PartnerThe hospital's Singapore Cancer Center is built on a clinical partnership with the National University Hospital of Singapore (NUHS). Singapore oncologists from NUHS, including Dr. Lim Hong Liang (former Vice Chairman of NUHS Medical Board), Dr. Zee Ying Kiat (from NCIS), and Dr. See Hui Ti (from Parkway Cancer Centre, Gleneagles Hospital), provide direct consultation and treatment oversight at Thu Cuc Hospital using Singapore-standard protocols.
• National University Cancer Institute Singapore (NCIS)coreStrategic or Co-development PartnerDr. Zee Ying Kiat, a consultant medical oncologist at NCIS, extends his oncology practice to Thu Cuc Hospital, providing gastrointestinal, liver, pancreatic, and colorectal cancer treatment with Singapore-standard protocols directly in Vietnam.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• FV Hospital: JCI-accredited French-Vietnamese private hospital in Ho Chi Minh City offering multi-specialty care including oncology to affluent Vietnamese and expatriate patients; comparable premium positioning and international-doctor model.
• Vinmec Healthcare System: Vietnam's largest private hospital chain operated by Vingroup. Directly comparable as a premium multi-specialty private hospital system targeting affluent Vietnamese patients with international-quality care across oncology and other specialties.
• Raffles Medical Group: Singapore-headquartered private healthcare group with hospitals across Asia. Comparable business model combining international physician networks with multi-specialty private care in regional Asian markets.
• Hoan My Medical Corporation: One of Vietnam's largest private hospital networks with multi-specialty offerings including oncology. Comparable private-hospital business model serving middle-class Vietnamese patients across multiple cities.
• Parkway Cancer Centre (Mount Elizabeth / Gleneagles): Singapore private oncology center where Thu Cuc partner Dr. See Hui Ti practices. Directly comparable for treatment protocols, pricing benchmarks, and as the alternative destination for Vietnamese medical tourists.

Regional players

• Bangkok Hospital (Bangkok Dusit Medical Services): Large Thai private hospital network with strong oncology and international-patient services. Comparable premium international hospital model serving regional medical travelers, though based in a different country.
• Bumrungrad International Hospital: Bangkok-based international hospital serving medical tourists across Southeast Asia, including Vietnamese patients. Comparable international-standard positioning and oncology capabilities, but based in Thailand rather than Vietnam.

Others

• Bệnh viện Ung bướu Hà Nội (Hanoi Oncology Hospital): Public specialty oncology hospital in Hanoi where Thu Cuc's Vietnamese department heads previously worked. Represents the public-sector local incumbent for cancer treatment in the same geography.
• Bệnh viện K (K Hospital): Vietnam's leading public national cancer hospital and a major referral center. Represents the public-sector benchmark for cancer treatment capacity in Vietnam and the primary incumbent for oncology volume.

Broad incumbents

• National University Cancer Institute, Singapore (NCIS): NUHS-affiliated comprehensive cancer center and Thu Cuc's clinical partner. Provides the protocol backbone and physician pipeline; comparable as the academic gold-standard oncology reference for Thu Cuc's 'Singapore-standard' positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/b%E1%BB%87nh-vi%E1%BB%87n-%C4%91a-khoa-qu%E1%BB%91c-t%E1%BA%BF-thu-c%C3%BAc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bệnh viện Đa khoa Quốc tế Thu Cúc